Latest Biotech News

A new distributed fusion framework for predicting breast cancer recurrence uses MapReduce-style computing to combine data across sites, according to researchers behind a recent report. The...

Researchers reported results from the phase II GETNE-DUTHY trial evaluating durvalumab plus tremelimumab in advanced thyroid cancer. The study, led by Capdevila, Hernando, and Molina-Cerillo,...

A study reports that blocking circulating glycocholic acid (GCA) can enhance colorectal cancer immunotherapy efficacy. The work links a specific bile-acid signaling factor to immune checkpoint...

Researchers uncovered a preprint plagiarism network that they say uses large language models to rephrase legitimate work posted on preprint servers. The investigation, described under “Fake...

A team reported a “set it and forget it” system to stop cyanobacteria-driven algae blooms using bacteria-busting buoys. In tests described in ACS ES&T Water, the tethered buoy design removed...

Beyond the Lilly approval itself, investors and analysts are weighing how rapidly oral GLP-1 competitors can convert regulatory gains into sustained prescriptions. The reporting tied Foundayo’s...

The White House proposed major budget cuts to US science agencies, including a 13% reduction for the National Institutes of Health and cuts exceeding 50% for the NSF and EPA compared with current...

A research advocacy group, United for Medical Research, reported that NIH grant money stimulated the US economy with a stated 250% return on investment. The report also warns that certain funding...

FDA approved Rocket Pharmaceuticals’ gene therapy Kresladi (marne-cel) for leukocyte adhesion deficiency type I, the company said, adding a rare pediatric disease priority review voucher to the...

A phase II GETNE-DUTHY trial is evaluating durvalumab plus tremelimumab in advanced thyroid cancer, according to the new report describing the study led by Capdevila, Hernando, and Molina-Cerillo....

Researchers report that whole-body diffusion-weighted MRI (WB-DWI/MRI) can predict outcomes after neoadjuvant chemotherapy for advanced ovarian cancer, in work published in the British Journal of...

A Nature Communications study provides real-world comparative safety evidence for second-line antihyperglycemic agents in elderly patients with type 2 diabetes, led by Kim, Bu, Blacketer, and...

Researchers report that circulating glycocholic acid (GCA) can modulate the efficacy of immune checkpoint therapy in colorectal cancer, in a study positioned as identifying a key biochemical...

A report on clinical outcomes and risks after post-ibrutinib transplant addresses how relapsed or refractory mantle cell lymphoma patients fare once they move from targeted therapy to...

A British Journal of Cancer study describes how targetable markers define antiprogestin-resistant breast cancer, focusing on endocrine resistance in luminal disease. The work, dated April 4, 2026,...

Researchers unveiled an ultra-flexible near-infrared vertical cavity surface emitting laser (VCSEL) aimed at improving skin-friendly photoplethysmography (PPG) monitoring, with details published...

A new study proposes representation learning to advance multi-institution electronic health record (EHR) studies across the United States and France, led by Zhou, Tong, and Wang. The approach is...

A finance report highlights Ambrosia and Syneron moving toward the clinic with nine-digit Series B rounds, positioning the funding to support late preclinical or early clinical execution. The...

FDA has approved Rocket Pharmaceuticals’ gene therapy Kresladi (marne-cel), targeting leukocyte adhesion deficiency type I, according to an FDA March approvals update from Rocket. The company said...

A phase II GETNE-DUTHY study is advancing a new combination approach for advanced thyroid cancer using checkpoint blockade with durvalumab and tremelimumab. The trial is led by Capdevila,...